Progesterone Vaginal Gel — FDA Drug Shortage

To Be Discontinued — AbbVie Inc.

The FDA lists a drug shortage record for Progesterone Vaginal Gel (vaginal gel) from AbbVie Inc. with status To Be Discontinued. The shortage was first posted on 03/27/2026.

Shortage Details

Status
To Be Discontinued
Company
AbbVie Inc.
Package NDC
0023-6150-04
Dosage Form
Vaginal Gel
Presentation
Crinone, Vaginal Gel, 4% (NDC 0023-6150-04)
Initial Posting
03/27/2026
Revised Date